Deutsche Bank Ag\ Alpine Immune Sciences, Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.75 - $41.6 $1.33 Million - $3.12 Million	75,000 Added 57.92%	204,479 $8.11 Million
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $956,206 - $2.26 Million	111,968 Added 639.42%	129,479 $2.47 Million
Q3 2023 Nov 09, 2023	SELL	$10.13 - $13.98 $1.11 Million - $1.54 Million	-109,814 Reduced 86.25%	17,511 $200,000
Q2 2023 Aug 14, 2023	BUY	$6.84 - $11.91 $770,006 - $1.34 Million	112,574 Added 763.16%	127,325 $1.31 Million
Q1 2023 May 15, 2023	BUY	$7.0 - $8.75 $46,172 - $57,715	6,596 Added 80.88%	14,751 $113,000
Q4 2022 Feb 13, 2023	BUY	$5.45 - $7.35 $577 - $779	106 Added 1.32%	8,155 $59,000
Q3 2022 Nov 14, 2022	SELL	$6.89 - $9.39 $7,165 - $9,765	-1,040 Reduced 11.44%	8,049 $58,000
Q2 2022 Aug 11, 2022	BUY	$6.71 - $9.52 $18,714 - $26,551	2,789 Added 44.27%	9,089 $77,000
Q1 2022 May 13, 2022	SELL	$6.41 - $13.89 $4,756 - $10,306	-742 Reduced 10.54%	6,300 $57,000
Q4 2021 Feb 11, 2022	BUY	$10.41 - $13.95 $3,768 - $5,049	362 Added 5.42%	7,042 $98,000
Q3 2021 Nov 04, 2021	SELL	$8.19 - $11.31 $1.04 Million - $1.44 Million	-127,377 Reduced 95.02%	6,680 $71,000
Q2 2021 Aug 11, 2021	SELL	$8.81 - $15.03 $971,522 - $1.66 Million	-110,275 Reduced 45.13%	134,057 $1.21 Million
Q1 2021 May 13, 2021	BUY	$10.02 - $13.92 $2.45 Million - $3.4 Million	244,332 New	244,332 $2.59 Million
Q1 2020 May 14, 2020	SELL	$2.15 - $4.41 $2,289 - $4,696	-1,065 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.45 - $3.87 $2,609 - $4,121	1,065 New	1,065 $4,000
Q1 2019 May 15, 2019	SELL	$4.09 - $7.19 $1,656 - $2,911	-405 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.68 - $6.07 $124,597 - $205,518	-33,858 Reduced 98.82%	405 $1,000
Q3 2018 Dec 21, 2021	SELL	$5.68 - $8.59 $11 - $17	-2 Reduced 0.01%	34,263 $217,000
Q3 2018 Nov 14, 2018	SELL	$5.68 - $8.59 $36,369 - $55,001	-6,403 Reduced 15.74%	34,265 $216,000
Q2 2018 Apr 21, 2020	SELL	$7.16 - $10.05 $14 - $20	-2 Reduced -0.0%	40,668 $308,000
Q2 2018 Aug 14, 2018	BUY	$7.16 - $10.05 $21,408 - $30,049	2,990 Added 7.94%	40,670 $307,000
Q1 2018 Oct 18, 2019	SELL	$7.95 - $11.65 $15 - $23	-2 Reduced 0.01%	37,680 $301,000
Q1 2018 May 15, 2018	BUY	$7.95 - $11.65 $162,100 - $237,543	20,390 Added 117.92%	37,682 $301,000
Q4 2017 Feb 14, 2018	SELL	$9.65 - $12.65 $47,574 - $62,364	-4,930 Reduced 22.19%	17,292 $193,000
Q3 2017 Nov 14, 2017	BUY	$8.0 - $11.6 $177,776 - $257,775	22,222	22,222 $257,000

Others Institutions Holding ALPN

# of Institutions

Shares Held

56.2K

Call Options Held

Put Options Held

View Full List

About ALPINE IMMUNE SCIENCES, INC.

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

More about ALPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account